GenSight Biologics
SIGHT.PA
#9709
Rank
S$44.29 M
Marketcap
$0.34
Share price
-0.65%
Change (1 day)
-43.18%
Change (1 year)

Earnings for GenSight Biologics (SIGHT.PA)

Earnings in 2023: -S$38.05 Million

According to GenSight Biologics's latest financial reports the company's current earnings are S$1.4 Million. In 2023 the company made an earning of -S$38.05 Million, an increase over its 2022 earnings that were of -S$38.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for GenSight Biologics from 2013 to 2023

Annual earnings

Year Earnings Change
2023-S$38.05 Million-2.16%
2022-S$38.89 Million-8.58%
2021-S$42.54 Million-22.54%
2020-S$54.92 Million21.01%
2019-S$45.39 Million-9.66%
2018-S$50.24 Million32.28%
2017-S$37.98 Million24.57%
2016-S$30.49 Million55.57%
2015-S$19.6 Million84%
2014-S$10.65 Million112.64%
2013-S$5.01 Million